Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Recurrence × Cyclophosphamide × Clear all

Phase

Status

Sponsor Class

OTHER 101 INDUSTRY 28 NIH 2 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Multiple Myeloma 3 Burkitt Lymphoma 3 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Solid Tumors 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Neoplasms by Site 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Disease Progression 1 Congenital Abnormalities 1 Breast Diseases 1 Breast Cancer Metastatic 1 Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited 1

Interventions

Surgical Procedures, Operative 2 Dexamethasone 2 temoporfin 1 pomalidomide 1 pembrolizumab 1 nimotuzumab 1 liposomal doxorubicin 1 ledipasvir 1 ibrutinib 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Thalidomide 1 Sofosbuvir 1 Rituximab 1 Ribavirin 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mitoxantrone 1 Mastectomy 1 Irinotecan 1 Immunotherapy, Adoptive 1 Hematologic Tests 1 Drug Therapy 1 Docetaxel 1 Diagnostic Imaging 1 Dermoscopy 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03601624 2018-11-14

MM-POM-2018

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Phase 2 Unknown

Multiple Myeloma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡